Global Postmenopausal Osteoporosis Treatment Market Size & Outlook
Global postmenopausal osteoporosis treatment market, 2018-2030 (US$M)
Related Markets
Global postmenopausal osteoporosis treatment market highlights
- The global postmenopausal osteoporosis treatment market generated a revenue of USD 10,432.2 million in 2024 and is expected to reach USD 13,702.8 million by 2030.
- The market is expected to grow at a CAGR (2025 - 2030) of 4.6% by 2030.
- In terms of segment, branded accounted for a revenue of USD 5,839.9 million in 2024.
- Generics is the most lucrative type segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
- Country-wise, Mexico is expected to register the highest CAGR from 2025 to 2030.
Global data book summary
| Market revenue in 2024 | USD 10,432.2 million |
| Market revenue in 2030 | USD 13,702.8 million |
| Growth rate | 4.6% (CAGR from 2025 to 2030) |
| Largest segment | Branded |
| Fastest growing segment | Generics |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Branded, Generics |
Other key industry trends
- In terms of revenue, the North America accounted for 39.4% of the global postmenopausal osteoporosis treatment market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Mexico is the fastest growing regional market and is projected to reach USD 152.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Postmenopausal Osteoporosis Treatment Market Scope
Postmenopausal Osteoporosis Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| No records found. | ||||
Global postmenopausal osteoporosis treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to postmenopausal osteoporosis treatment market will help companies and investors design strategic landscapes.
Branded was the largest segment with a revenue share of 55.98% in 2024. Horizon Databook has segmented the Global postmenopausal osteoporosis treatment market based on branded, generics covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Postmenopausal Osteoporosis Treatment Type Outlook (Revenue, USD Million, 2018-2030)
- Generics
- Branded
- Global Postmenopausal Osteoporosis Treatment Drug Class Outlook (Revenue, USD Million, 2018-2030)
- Parathyroid Hormone Therapy
- Selective Estrogen Inhibitors Modulator(SERM)
- Bisphosphonates
- Calcitonin
- Rank Ligand Inhibitors
- Other Drug Class
- Global Postmenopausal Osteoporosis Treatment Distribution Channel Outlook (Revenue, USD Million, 2018-2030)
- Retail Pharmacies
- Online Pharmacies
- Hospital Pharmacies
Reasons to subscribe to Global postmenopausal osteoporosis treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global postmenopausal osteoporosis treatment market databook
-
Our clientele includes a mix of postmenopausal osteoporosis treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global postmenopausal osteoporosis treatment market , including forecasts for subscribers. This global databook contains high-level insights into Global postmenopausal osteoporosis treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global postmenopausal osteoporosis treatment market size, by regions, 2018-2030 (US$M)
Top 10 countries: Postmenopausal osteoporosis treatment market size, 2024 (US$M)
Global postmenopausal osteoporosis treatment market share, by distribution channel, 2024 & 2030 (%, US$M)
Postmenopausal osteoporosis treatment market: Opportunity assessment by country
Global postmenopausal osteoporosis treatment market, by region, 2024 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
